Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02849171
What this trial is testing

Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas

Who this might be right for
Brain Cancer
Memorial Sloan Kettering Cancer Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT06467799
What this trial is testing

Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC

Who this might be right for
Hepatocellular CarcinomaBeyond Milan Criteria
Sun Yat-sen University 39
Testing effectiveness (Phase 2)Looking for participantsNCT05557604
What this trial is testing

Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer

Who this might be right for
Prostate Cancer
Regina Elena Cancer Institute 146
Large-scale testing (Phase 3)Study completedNCT00005863
What this trial is testing

Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Medical Research Council
Testing effectiveness (Phase 2)Looking for participantsNCT06483906
What this trial is testing

Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.

Who this might be right for
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 56
Large-scale testing (Phase 3)Study completedNCT00887536
What this trial is testing

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,613
Not applicableLooking for participantsNCT06672302
What this trial is testing

A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer

Who this might be right for
Breast Neoplasm
EXoPERT 330
Not applicableStudy completedNCT05495529
What this trial is testing

Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors

Who this might be right for
Radiology, InterventionalLiver NeoplasmCarcinoma, Hepatocellular (RENI)+4 more
Centre Hospitalier Universitaire de Nice 61
Not applicableStudy completedNCT00789607
What this trial is testing

Fiducial Localization and Individualized Radiotherapy -Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 17
Not applicableWithdrawnNCT04778566
What this trial is testing

Evaluating the Cologuard Test for Use in Lynch Syndrome

Who this might be right for
Lynch SyndromeColorectal CancerColonic Adenoma+1 more
Geisinger Clinic
Testing effectiveness (Phase 2)UnknownNCT05054465
What this trial is testing

A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
Israeli Medical Association 48
Testing effectiveness (Phase 2)Looking for participantsNCT04047641
What this trial is testing

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaBlasts 20 Percent or More of Bone Marrow Nucleated CellsHigh Risk Myelodysplastic Syndrome+5 more
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Ended earlyNCT01531205
What this trial is testing

Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 2
Early research (Phase 1)Study completedNCT01208454
What this trial is testing

Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma

Who this might be right for
Localized Unresectable NeuroblastomaRecurrent NeuroblastomaRegional Neuroblastoma+2 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT00291694
What this trial is testing

Protocol for Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 72
Not applicableUnknownNCT02327494
What this trial is testing

Study to Evaluate Oxygen Monitoring at Different Stages of Neuromuscular Blockade in Colorectal Surgery

Who this might be right for
Colorectal Cancer
Hospital Universitari de Bellvitge 70
Large-scale testing (Phase 3)Looking for participantsNCT07285239
What this trial is testing

Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
PrECOG, LLC. 500
Not applicableUnknownNCT05282745
What this trial is testing

Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL

Who this might be right for
HPV InfectionHSIL, High-Grade Squamous Intraepithelial LesionsViral Load
Fujian Maternity and Child Health Hospital 4,000
Large-scale testing (Phase 3)Study completedNCT00003972
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

Who this might be right for
Breast Cancer
Fred Hutchinson Cancer Center 280
Early research (Phase 1)Ended earlyNCT01269411
What this trial is testing

RO4929097 in Treating Patients With Recurrent Invasive Gliomas

Who this might be right for
Adult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 22
Next Page